Magnetic resonance imaging in prostate cancer
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
32 0
Căutarea după subiecte
similare conform CZU
616.65-006-073.7 (3)
Patologia sistemului urogenital. Boli urinare şi sexuale (genitale) (413)
SM ISO690:2012
TAHA, Mario. Magnetic resonance imaging in prostate cancer. In: Moldovan Medical Journal, 2018, nr. 61(S_RMI), p. 57. ISSN 2537-6373.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Moldovan Medical Journal
Numărul 61(S_RMI) / 2018 / ISSN 2537-6373 /ISSNe 2537-6381

Magnetic resonance imaging in prostate cancer

CZU: 616.65-006-073.7

Pag. 57-57

Taha Mario
 
Medcor & Acc Medical, Odessa
 
 
Disponibil în IBN: 17 mai 2024


Rezumat

Background: Prostate cancer is a major problem in urology and requires focused attention for early imaging diagnosis. At the moment, magnetic resonance imaging (MRI) based upon PIRADS criteria is the state-of-the-art imaging standard. Content: PIRADS – what it means and what important components are included in this system? We will discuss MRI methodology and obligatory requirements for multi-parametric and bi-parametric prostate scanning according to the last European & US societies guidelines. Imaging prostate anatomy, appropriate terminology and interpretation criteria will be presented with case-based discussion. Some frequent pitfalls and misinterpretations will be highlighted. Conclusions: Attendees will get familiar with MRI PIRADS imaging features, common pitfalls and diagnostic challenges.

Cuvinte-cheie
prostate cancer, magnetic resonance imaging